Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis

BACKGROUND: Cisplatin (CDDP)-induced nephrotoxicity is the most important complication of CDDP treatment. 5-Hydroxytryptamine type 3 receptor antagonists (5-HT(3)RAs) are widely used to prevent chemotherapy-induced nausea and vomiting (CINV). However, in patients with the triple antiemetic (neurokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemura, Miho, Ikemura, Kenji, Kondo, Masayoshi, Yamane, Fumihiro, Ueda, Mikiko, Okuda, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341052/
https://www.ncbi.nlm.nih.gov/pubmed/35909131
http://dx.doi.org/10.1186/s40780-022-00252-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341052/
https://www.ncbi.nlm.nih.gov/pubmed/35909131
http://dx.doi.org/10.1186/s40780-022-00252-z

Ejemplares similares